Pharmacological and Behavioral Treatment After Bariatric Surgery

StatusCompleted
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of Jan 12, 2027 to May 25, 2026
    • Eligibility criteria expanded, about 29 words
    • Secondary endpoints: details revised at 8 of 14 entries
  2. Phase: Phase 2/3 to Phase 3
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 160 to confirmed 84
    • Site details revised
    v7
  3. Study completion date: Jan 12, 2027 to Jan 12, 2028v6
  4. Study completion date: Jan 12, 2028 to Jan 12, 2027v5
  5. Collaborators expanded, about 10 wordsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Primary completion date: Nov 17, 2027 to Jan 12, 2027
    • Study completion date: Nov 17, 2028 to Jan 12, 2028
    • Start date changed from estimate of Dec 6, 2021 to Jan 13, 2022
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yale University
490 trials monitored
See 31 trials at risk
Obesity
3,888 trials monitored
See 157 trials at risk
This study will compare the effectiveness of behavioral and pharmacologic treatment, alone and combined, for improvements in weight loss, cardiovascular risk factors, and psychosocial functioning following metabolic and bariatric surgery.
Trial Details
NCT Number NCT05157698
Lead Sponsor Yale University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Obesity
Related terms Obesity
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov